Cargando…

1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals

BACKGROUND: Pneumocystis pneumonia (PcP) is a life-threatening condition for patients with HIV and other immunocompromised patients. Effective treatment requires timely diagnosis, but little is known about the frequency of diagnostic delays. METHODS: We conducted a retrospective cohort study using t...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Aaron, Polgreen, Philip M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252991/
http://dx.doi.org/10.1093/ofid/ofy210.1315
_version_ 1783373393181016064
author Miller, Aaron
Polgreen, Philip M
author_facet Miller, Aaron
Polgreen, Philip M
author_sort Miller, Aaron
collection PubMed
description BACKGROUND: Pneumocystis pneumonia (PcP) is a life-threatening condition for patients with HIV and other immunocompromised patients. Effective treatment requires timely diagnosis, but little is known about the frequency of diagnostic delays. METHODS: We conducted a retrospective cohort study using the Truven Health Analytics Commercial Claims and Encounters Database from 2011 to 2016. We identified index case visits for PcP as the point at which a patient was first diagnosed with PcP. We analyzed visits prior to the index diagnosis for symptoms related to PcP; these symptoms included cough, fever, dyspnea, pneumonia or other respiratory infections. We performed a change-point analysis to identify the time window before the index PcP diagnosis where diagnostic opportunities began to appear. We used a simulation model to estimate the likelihood of potential delays representing actual diagnostic opportunities. RESULTS: In our cohort, we identified 7,656 case patients with PcP, 5,187 in patients with HIV and 2,469 in patients without HIV. We observed a dramatic spike in hospitalizations, ED visits and outpatient visits for symptoms associated with PcP in the period just before the index PcP Diagnosis (see figure). In the time prior to the index PcP diagnosis, we identified 15,963 visits, and 4,674 patients, with at least one symptom of PcP. Of these potential opportunities, we estimated that 5,396 visits (CI 5,256–5,542), in 2,868 patients (CI 2,813–2,925), represented likely diagnostic delays. Around 56% of diagnostic opportunities occurred within 14 days of the PcP diagnosis, and 72% occurred within 3 weeks. Diagnostic delays were most likely to occur in outpatient settings: 4,429 outpatient opportunities (CI 4,546–4,679) compared with 674 (CI 706–738) inpatient or ED opportunities. Patients without HIV were more likely to experience a diagnostic delay: 77.4% (CI 74.7–80.2) of non-HIV patients, compared with 18.5% (CI 17.7–19.2) of HIV patients, experienced a delay. Diagnostic delays tended to be longer in patients without HIV, 16.1 days (15.7–16.4), compared with patients with HIV, 14.9 days (CI 14.8–15.1). CONCLUSION: Many opportunities to diagnoses PcP are missed or delayed, especially in outpatient settings. Patients without HIV are at greater risk of experiencing a diagnostic delay, and may experience delays of longer duration. [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6252991
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62529912018-11-28 1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals Miller, Aaron Polgreen, Philip M Open Forum Infect Dis Abstracts BACKGROUND: Pneumocystis pneumonia (PcP) is a life-threatening condition for patients with HIV and other immunocompromised patients. Effective treatment requires timely diagnosis, but little is known about the frequency of diagnostic delays. METHODS: We conducted a retrospective cohort study using the Truven Health Analytics Commercial Claims and Encounters Database from 2011 to 2016. We identified index case visits for PcP as the point at which a patient was first diagnosed with PcP. We analyzed visits prior to the index diagnosis for symptoms related to PcP; these symptoms included cough, fever, dyspnea, pneumonia or other respiratory infections. We performed a change-point analysis to identify the time window before the index PcP diagnosis where diagnostic opportunities began to appear. We used a simulation model to estimate the likelihood of potential delays representing actual diagnostic opportunities. RESULTS: In our cohort, we identified 7,656 case patients with PcP, 5,187 in patients with HIV and 2,469 in patients without HIV. We observed a dramatic spike in hospitalizations, ED visits and outpatient visits for symptoms associated with PcP in the period just before the index PcP Diagnosis (see figure). In the time prior to the index PcP diagnosis, we identified 15,963 visits, and 4,674 patients, with at least one symptom of PcP. Of these potential opportunities, we estimated that 5,396 visits (CI 5,256–5,542), in 2,868 patients (CI 2,813–2,925), represented likely diagnostic delays. Around 56% of diagnostic opportunities occurred within 14 days of the PcP diagnosis, and 72% occurred within 3 weeks. Diagnostic delays were most likely to occur in outpatient settings: 4,429 outpatient opportunities (CI 4,546–4,679) compared with 674 (CI 706–738) inpatient or ED opportunities. Patients without HIV were more likely to experience a diagnostic delay: 77.4% (CI 74.7–80.2) of non-HIV patients, compared with 18.5% (CI 17.7–19.2) of HIV patients, experienced a delay. Diagnostic delays tended to be longer in patients without HIV, 16.1 days (15.7–16.4), compared with patients with HIV, 14.9 days (CI 14.8–15.1). CONCLUSION: Many opportunities to diagnoses PcP are missed or delayed, especially in outpatient settings. Patients without HIV are at greater risk of experiencing a diagnostic delay, and may experience delays of longer duration. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6252991/ http://dx.doi.org/10.1093/ofid/ofy210.1315 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Miller, Aaron
Polgreen, Philip M
1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
title 1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
title_full 1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
title_fullStr 1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
title_full_unstemmed 1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
title_short 1486. Missed and Delayed Diagnosis of Pneumocystis Pneumonia in HIV and Non-HIV-Infected Individuals
title_sort 1486. missed and delayed diagnosis of pneumocystis pneumonia in hiv and non-hiv-infected individuals
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252991/
http://dx.doi.org/10.1093/ofid/ofy210.1315
work_keys_str_mv AT milleraaron 1486missedanddelayeddiagnosisofpneumocystispneumoniainhivandnonhivinfectedindividuals
AT polgreenphilipm 1486missedanddelayeddiagnosisofpneumocystispneumoniainhivandnonhivinfectedindividuals